Research demonstrates anti-inflammatory and pro-apoptotic effects of nano-liposomal myricetin, implying potential therapeutic benefits in liver disorders.
A naturally occurring flavonoid present in many fruits and vegetables, myricetin has garnered a lot of attention due to its possible anticancer effects. Heat-induced denaturation of bovine serum albumin was used to measure anti-inflammatory activity, and histopathological analysis was used to measure hepatoprotective effects. Furthermore, flow cytometry was used to assess myricetin's capacity to cause apoptosis. Protein denaturation was significantly inhibited by nano-liposomal myricetin in a concentration-dependent manner, with 59.1% inhibition at 100 µM, which is comparable to diclofenac sodium. Apoptotic cell populations increased dose- and time-dependently, reaching 75% at the highest concentration of 198 µM after 24 hours, according to flow cytometric analysis. These results demonstrate the potential of nano-liposomal myricetin as a natural therapeutic agent against hepatocellular carcinoma and inflammation-associated liver disorders by effectively inhibiting protein denaturation and promoting programmed cell death.
No takes yet. Share an insight, caveat, or question.
Verma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: